Back
BridgeBio Pharma Vs. Bristol-Myers Squibb Industry Stock Comparison
Buy
57
BBIO
BridgeBio Pharma
Last Price:
24.10
Seasonality Move:
13.43%
Buy
61
BMY
Bristol-Myers Squibb
Last Price:
58.51
Seasonality Move:
1.84%
Buy
57
BridgeBio Pharma (BBIO)
is a Buy
Is BridgeBio Pharma a Buy, Sell or Hold?
- The current BridgeBio Pharma [BBIO] share price is $24.79. The Score for BBIO is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- BBIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
Bristol-Myers Squibb (BMY)
is a Buy
Is Bristol-Myers Squibb a Buy, Sell or Hold?
- The current Bristol-Myers Squibb [BMY] share price is $58.41. The Score for BMY is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- BMY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BBIO Stock Price Chart
What is BridgeBio Pharma's stock price today?
-
The BridgeBio Pharma share price today is $24.79
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBIO is experiencing selling pressure, which indicates risk of future bearish movement.
BMY Stock Price Chart
What is Bristol-Myers Squibb's stock price today?
-
The Bristol-Myers Squibb share price today is $58.41
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMY is experiencing slight selling pressure.
BBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 47.06 | Sell |
| Chaikin Money Flow: | -1475647 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.15 - 25.99) | Sell |
| Bollinger Bands (100): | (24.16 - 27.4) | Sell |
BMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.61 | Buy |
| Relative Strength Index (14 RSI): | 64.98 | Buy |
| Chaikin Money Flow: | -3314717 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.93 - 56.29) | Buy |
| Bollinger Bands (100): | (44.15 - 53.57) | Buy |
BBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.6 | Sell |
| 20-day SMA: | 25.07 | Sell |
| 50-day SMA: | 25.87 | Sell |
| 200-day SMA: | 27.68 | Sell |
| 8-day EMA: | 25.33 | Sell |
| 20-day EMA: | 25.23 | Sell |
| 50-day EMA: | 25.48 | Sell |
| 200-day EMA: | 26.72 | Sell |
BMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.6 | Buy |
| 20-day SMA: | 54.5 | Buy |
| 50-day SMA: | 52.34 | Buy |
| 200-day SMA: | 48.2 | Buy |
| 8-day EMA: | 56.87 | Buy |
| 20-day EMA: | 55.09 | Buy |
| 50-day EMA: | 52.71 | Buy |
| 200-day EMA: | 50.29 | Buy |
BridgeBio Pharma Earnings Growth & BBIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.77 per share, and a decrease next year of $0.66 per share.
Bristol-Myers Squibb Earnings Growth & BMY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.50 per share, and an increase next year of $6.16 per share.
BridgeBio Pharma Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bristol-Myers Squibb Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||